(Q39183368)

9 September 2017

Effect of antipsychotic and other classes of drugs on spontaneous locomotor activity and neurotoxicity in mice (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

25 March 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

25 March 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

25 March 2022

author name string

McLean JR

1

1 reference

9 September 2017

J. R. McLean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A24225

25 March 2022

R. B. Parker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A24225

25 March 2022

L. L. Coughenour

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A24225

25 March 2022

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

9 September 2017

https://api.elsevier.com/content/article/PII:0091305778901302?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

https://api.elsevier.com/content/article/PII:0091305778901302?httpAccept=text/plain

25 March 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Pharmacology, Biochemistry and Behavior

25 March 2022

published in

1 reference

9 September 2017

8

1 reference

9 September 2017

97-99

1 reference

9 September 2017

1

1 reference

Evidence for a central noradrenaline receptor stimulation by clonidine.

9 September 2017

1

9

513

Evidence for a central noradrenaline receptor stimulation by clonidine (English)

0 references

A new device for the rapid measurement of impaired motor function in mice

2

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

23 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs

23 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

A preliminary procedure for the evaluation of central nervous system depressants

23 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system

23 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Antipsychotic drug doses and neuroleptic/dopamine receptors

23 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

A Preliminary Evaluation of the Sedative Effects of Catapres, a New Antihypertensive Agent, in Chronic Schizophrenic Patients

23 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

Propranolol in the control of schizophrenic symptoms

23 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90130-2

23 October 2022

Identifiers

1 reference

9 September 2017

1 reference